Silence Therapeutics plc (SLN) /
The revenue of Silence Therapeutics plc over the past 4 years
Chart Silence Therapeutics plc: revenue, fiscal 2022–2025 Open the chart →Silence Therapeutics plc reported revenue of $559K in fiscal 2025, the latest fiscal year on file. In fiscal 2022 it was $21.66M — down 97% over 3 years. Year over year, revenue rose twice and fell once. In these years the highest was $43.26M in fiscal 2024; the lowest $559K in fiscal 2025. The largest one-year move was in fiscal 2025: down 99%, from $43.26M to $559K.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $559K |
| 2024ended Dec 31, 2024 | $43.26M |
| 2023ended Dec 31, 2023 | $31.64M |
| 2022ended Dec 31, 2022 | $21.66M |
Fiscal years as Silence Therapeutics plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Silence Therapeutics plc
- The profitability of Silence Therapeutics plc
- The cash flow of Silence Therapeutics plc
- The debt of Silence Therapeutics plc
- All of Silence Therapeutics plc's financials, charted
Companies of a similar size
- GRBKGreen Brick Partners, Inc.
- ASANAsana, Inc.
- CWKCushman & Wakefield Ltd.
- FBKFB FINANCIAL CORPORATION
- BTUPEABODY ENERGY CORP
Not investment advice. This page shows what Silence Therapeutics plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.